Context-dependent regulation of the expression of c-Ski protein by Arkadia in human cancer cells.

Arkadia is a positive regulator of transforming growth factor-beta (TGF-beta) signalling, which induces ubiquitylation and proteasome-dependent degradation of negative regulators of the TGF-beta signalling pathway, i.e. Smad7, c-Ski and SnoN. In the present study, we examined the roles of Arkadia in human cancer cells. We first examined the expression of Arkadia in 20 cancer cell lines and 2 non-cancerous cell lines, and found that it was expressed ubiquitously at both the mRNA and protein levels. Interestingly, levels of expression of c-Ski protein, one of the substrates of Arkadia, were not correlated with those of c-Ski mRNA. Arkadia induced down-regulation of c-Ski protein expression in many cell lines examined, but did not in certain cell lines with high levels of expression of c-Ski protein. We also found that knockdown of Arkadia attenuated the induction of TGF-beta target genes, whereas ectopically expressed Arkadia enhanced it. Notably, over-expression of Arkadia inhibited the growth of HepG2 cells in the presence as well as the absence of TGF-beta stimulation. Arkadia thus regulates the levels of expression of c-Ski protein in cell-type-dependent fashion, and exhibits a tumour suppressor function by inhibiting tumour cell growth.

[1]  Hiroshi I. Suzuki,et al.  c‐Ski overexpression promotes tumor growth and angiogenesis through inhibition of transforming growth factor‐β signaling in diffuse‐type gastric carcinoma , 2009, Cancer science.

[2]  H. Aburatani,et al.  Diffuse-Type Gastric Carcinoma: Progression, Angiogenesis, and Transforming Growth Factor β Signaling , 2009 .

[3]  J. Inazawa,et al.  SKI and MEL1 Cooperate to Inhibit Transforming Growth Factor-β Signal in Gastric Cancer Cells* , 2009, Journal of Biological Chemistry.

[4]  Luzhe Sun,et al.  Transforming growth factor-beta suppresses the ability of Ski to inhibit tumor metastasis by inducing its degradation. , 2008, Cancer research.

[5]  Konstantinos J. Mavrakis,et al.  Arkadia Induces Degradation of SnoN and c-Ski to Enhance Transforming Growth Factor-β Signaling* , 2007, Journal of Biological Chemistry.

[6]  Konstantinos J. Mavrakis,et al.  Arkadia Enhances Nodal/TGF-β Signaling by Coupling Phospho-Smad2/3 Activity and Turnover , 2007, PLoS biology.

[7]  Brian Bierie,et al.  Tumour microenvironment: TGFβ: the molecular Jekyll and Hyde of cancer , 2006, Nature Reviews Cancer.

[8]  K. Miyazono,et al.  Smad Transcriptional Co-Activators and Co-Repressors , 2006 .

[9]  R. Derynck,et al.  Specificity and versatility in tgf-beta signaling through Smads. , 2005, Annual review of cell and developmental biology.

[10]  K. Miyazawa,et al.  Involvement of down-regulation of Cdk2 activity in hepatocyte growth factor-induced cell cycle arrest at G1 in the human hepatocellular carcinoma cell line HepG2. , 2004, Journal of biochemistry.

[11]  K. Miyazono,et al.  c-Ski inhibits the TGF-β signaling pathway through stabilization of inactive Smad complexes on Smad-binding elements , 2004, Oncogene.

[12]  M. Kitagawa,et al.  Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. Herrmann,et al.  Amplification of SKI is a prognostic marker in early colorectal cancer. , 2004, Neoplasia.

[14]  H. Kuwano,et al.  Increased expression of c‐Ski as a co‐repressor in transforming growth factor‐β signaling correlates with progression of esophageal squamous cell carcinoma , 2004, International journal of cancer.

[15]  K. Luo.  Ski and SnoN: negative regulators of TGF-β signaling , 2004 .

[16]  K. Miyazono,et al.  Interaction with Smad4 is indispensable for suppression of BMP signaling by c-Ski. , 2003, Molecular biology of the cell.

[17]  H. Nakauchi,et al.  CD226 (DNAM-1) Is Involved in Lymphocyte Function–associated Antigen 1 Costimulatory Signal for Naive T Cell Differentiation and Proliferation , 2003, The Journal of experimental medicine.

[18]  J. Isola,et al.  Ski-related novel protein N (SnoN), a negative controller of transforming growth factor-beta signaling, is a prognostic marker in estrogen receptor-positive breast carcinomas. , 2003, Cancer research.

[19]  L. Wakefield,et al.  The two faces of transforming growth factor β in carcinogenesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Massagué,et al.  Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus , 2003, Cell.

[21]  H. Nakauchi,et al.  CD 226 ( DNAM-1 ) Is Involved in Lymphocyte Function – associated Antigen 1 Costimulatory Signal for Naive T Cell Differentiation and Proliferation , 2003 .

[22]  L. Wakefield,et al.  The two faces of transforming growth factor beta in carcinogenesis. , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Takeshi Imamura,et al.  Arkadia amplifies TGF-beta superfamily signalling through degradation of Smad7. , 2003, The EMBO journal.

[24]  K. Miyazono,et al.  Two major Smad pathways in TGF‐β superfamily signalling , 2002, Genes to cells : devoted to molecular & cellular mechanisms.

[25]  Yigong Shi,et al.  Structural Mechanism of Smad4 Recognition by the Nuclear Oncoprotein Ski Insights on Ski-Mediated Repression of TGF-β Signaling , 2002, Cell.

[26]  P. Goldschmidt-Clermont,et al.  Deficient Smad7 expression: A putative molecular defect in scleroderma , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[27]  S. Ishii,et al.  Increased susceptibility to tumorigenesis of ski-deficient heterozygous mice , 2001, Oncogene.

[28]  E. Medrano,et al.  Cytoplasmic localization of the oncogenic protein Ski in human cutaneous melanomas in vivo: functional implications for transforming growth factor beta signaling. , 2001, Cancer research.

[29]  N. Nomura,et al.  SNO is a probable target for gene amplification at 3q26 in squamous-cell carcinomas of the esophagus. , 2001, Biochemical and biophysical research communications.

[30]  T. Macdonald,et al.  Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease. , 2001, The Journal of clinical investigation.

[31]  R. Arkell,et al.  Induction of the mammalian node requires Arkadia function in the extraembryonic lineages , 2001, Nature.

[32]  J. Walsh,et al.  Arkadia enhances nodal-related signalling to induce mesendoderm , 2001, Nature.

[33]  J. Massagué,et al.  TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders , 2000, Cell.

[34]  J. Campisi,et al.  Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[35]  S. Ishii,et al.  The sno gene, which encodes a component of the histone deacetylase complex, acts as a tumor suppressor in mice , 2000, The EMBO journal.

[36]  H. Lodish,et al.  Role of transforming growth factor beta in human disease. , 2000, The New England journal of medicine.

[37]  J. Wrana,et al.  Smads as transcriptional co-modulators. , 2000, Current opinion in cell biology.

[38]  K. Miyazono,et al.  c-Ski Acts as a Transcriptional Co-repressor in Transforming Growth Factor-β Signaling through Interaction with Smads* , 1999, The Journal of Biological Chemistry.

[39]  R. Weinberg,et al.  SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor beta signaling. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[40]  K. Luo,et al.  Negative Feedback Regulation of TGF-β Signaling by the SnoN Oncoprotein , 1999 .

[41]  H. Friess,et al.  The TGF-β signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer , 1999, Oncogene.

[42]  Qiang Zhou,et al.  The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling. , 1999, Genes & development.

[43]  S. Ishii,et al.  Ski is a component of the histone deacetylase complex required for transcriptional repression by Mad and thyroid hormone receptor. , 1999, Genes & development.

[44]  C. Heldin,et al.  Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling , 1997, Nature.

[45]  J. Wrana,et al.  The MAD-Related Protein Smad7 Associates with the TGFβ Receptor and Functions as an Antagonist of TGFβ Signaling , 1997, Cell.

[46]  C. Heldin,et al.  Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. , 1997, Nature.

[47]  K. Miyazono,et al.  TGF-beta signalling from cell membrane to nucleus through SMAD proteins. , 1997, Nature.

[48]  E. Stavnezer,et al.  Unique sequence, ski, in Sloan-Kettering avian retroviruses with properties of a new cell-derived oncogene , 1986, Journal of virology.